New AIAG Survey Explores the Future of Corporate Responsibility
Dec 13, 2017 21:11 pm UTC| Business
SOUTHFIELD, Mich., Dec. 13, 2017 -- It all began with a question: What corporate responsibility issues will the automotive industry encounter over the next decade? In response to this inquiry, the Automotive Industry...
Schmitt Industries Announces Second Quarter Fiscal 2018 Operating Results
Dec 13, 2017 21:10 pm UTC| Business
PORTLAND, Ore., Dec. 13, 2017 -- Schmitt Industries, Inc. (NASDAQ:SMIT) today announced its operating results for the three and six months ended November 30, 2017. For the three months ended November 30, 2017, total...
Dec 13, 2017 21:05 pm UTC| Business
JACKSONVILLE, Fla., Dec. 13, 2017 -- Web.com Group, Inc. (Nasdaq:WEB), a leading global provider of a full range of internet services and online marketing solutions for small businesses, is proud to announce that...
The Chefs’ Warehouse, Inc. Completes Repricing of Credit Facility
Dec 13, 2017 21:05 pm UTC| Business
RIDGEFIELD, Conn., Dec. 13, 2017 -- The Chefs’ Warehouse, Inc. (NASDAQ:CHEF) (“the Company”) today announced that it has completed the repricing of its existing $289 million term loans under its senior secured term loan...
Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee
Dec 13, 2017 21:05 pm UTC| Business
Acquisition complements existing portfolio with an innovative, locally administered therapeutic intended to provide persistent effective concentrations of IL-1Ra in the knee for at least a yearNew preclinical program holds...
Oil-Dri Board of Directors Declares Quarterly Dividends
Dec 13, 2017 21:05 pm UTC| Business
CHICAGO, Dec. 13, 2017 -- The Board of Directors of Oil-Dri Corporation of America (NYSE:ODC) yesterday declared quarterly cash dividends of $0.23 per share of the Company’s Common Stock and $0.173 per share of the...
Nabriva Therapeutics Added to NASDAQ Biotechnology Index
Dec 13, 2017 21:05 pm UTC| Business
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 13, 2017 -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to...